BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15982582)

  • 1. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
    Govindan SV; Michel RB; Griffiths GL; Goldenberg DM; Mattes MJ
    Nucl Med Biol; 2005 Jul; 32(5):513-9. PubMed ID: 15982582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.
    Michel RB; Brechbiel MW; Mattes MJ
    J Nucl Med; 2003 Apr; 44(4):632-40. PubMed ID: 12679410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
    Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
    J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-Specific
    Yue TTC; Ge Y; Aprile FA; Ma MT; Pham TT; Long NJ
    Bioconjug Chem; 2023 Oct; 34(10):1802-1810. PubMed ID: 37751398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions.
    Caraco C; Aloj L; Eckelman WC
    Appl Radiat Isot; 1998 Dec; 49(12):1477-9. PubMed ID: 9745687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
    J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
    Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
    J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
    Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
    Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of
    Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving Beyond Isothiocyanates: A Look at the Stability of Conjugation Links Toward Radiolysis in
    Vizier R; Adumeau P; Moreau M; Goncalves V; Denat F
    Bioconjug Chem; 2024 May; 35(5):633-637. PubMed ID: 38656148
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ioppolo JA; Caldwell D; Beiraghi O; Llano L; Blacker M; Valliant JF; Berti PJ
    Nucl Med Biol; 2017 Sep; 52():32-41. PubMed ID: 28602965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature.
    Velikyan I; Maecke H; Langstrom B
    Bioconjug Chem; 2008 Feb; 19(2):569-73. PubMed ID: 18205327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
    Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
    J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
    Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
    J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.
    Rossi NA; Mustafa I; Jackson JK; Burt HM; Horte SA; Scott MD; Kizhakkedathu JN
    Biomaterials; 2009 Feb; 30(4):638-48. PubMed ID: 18977029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
    Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
    Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Heskamp S; Raavé R; Boerman O; Rijpkema M; Goncalves V; Denat F
    Bioconjug Chem; 2017 Sep; 28(9):2211-2223. PubMed ID: 28767228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals.
    Burke BP; Clemente GS; Archibald SJ
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):239-43. PubMed ID: 24497011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
    Yamaoka S
    Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.